Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Beginning balance at Jan. 31, 2021 $ 31,541 $ 378 $ 246,446 $ (227) $ (73) $ (214,983)
Beginning balance, Shares at Jan. 31, 2021   37,811,224        
Issuance of common stock pursuant to vesting of restricted stock units   $ 10 (10)      
Issuance of common stock pursuant to vesting of restricted stock units, shares   981,927        
Issuance of common stock pursuant to exercise of stock options 137 $ 1 136      
Issuance of common stock pursuant to exercise of stock options, shares   95,538        
Issuance of common stock, net of issuance costs 17,462 $ 103 17,359      
Issuance of common stock, net of issuance costs, shares   10,323,484        
Stock-based compensation expense 1,041   1,041      
Unrealized gains on marketable securities 1       1  
Foreign currency translation adjustment (358)       (358)  
Net income (loss) (3,841)         (3,841)
Ending balance at Jul. 31, 2021 45,983 $ 492 264,972 (227) (430) (218,824)
Ending balance, Shares at Jul. 31, 2021   49,212,173        
Beginning balance at Apr. 30, 2021 45,322 $ 484 264,147 (227) (31) (219,051)
Beginning balance, Shares at Apr. 30, 2021   48,408,342        
Issuance of common stock pursuant to vesting of restricted stock units   $ 8 (8)      
Issuance of common stock pursuant to vesting of restricted stock units, shares   803,831        
Stock-based compensation expense 833   833      
Foreign currency translation adjustment (399)       (399)  
Net income (loss) 227         227
Ending balance at Jul. 31, 2021 45,983 $ 492 264,972 (227) (430) (218,824)
Ending balance, Shares at Jul. 31, 2021   49,212,173        
Beginning balance at Jan. 31, 2022 42,524 $ 493 265,644 (227) (973) (222,413)
Beginning balance, Shares at Jan. 31, 2022   49,347,604        
Issuance of common stock pursuant to vesting of restricted stock units   $ 8 (8)      
Issuance of common stock pursuant to vesting of restricted stock units, shares   829,220        
Stock-based compensation expense 534   534      
Foreign currency translation adjustment (1,051)       (1,051)  
Short swing profit settlement 7   7      
Net income (loss) (9,447)         (9,447)
Ending balance at Jul. 31, 2022 32,567 $ 501 266,177 (227) (2,024) (231,860)
Ending balance, Shares at Jul. 31, 2022   50,176,824        
Beginning balance at Apr. 30, 2022 39,236 $ 494 265,927 (227) (1,549) (225,409)
Beginning balance, Shares at Apr. 30, 2022   49,418,721        
Issuance of common stock pursuant to vesting of restricted stock units   $ 7 (7)      
Issuance of common stock pursuant to vesting of restricted stock units, shares   758,103        
Stock-based compensation expense 250   250      
Foreign currency translation adjustment (475)       (475)  
Short swing profit settlement 7   7      
Net income (loss) (6,451)         (6,451)
Ending balance at Jul. 31, 2022 $ 32,567 $ 501 $ 266,177 $ (227) $ (2,024) $ (231,860)
Ending balance, Shares at Jul. 31, 2022   50,176,824